Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | bisacodyl | 19090 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | bisacodyl | 19090 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | bisacodyl | 19090 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | bisacodyl | 19090 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | bisacodyl | 19090 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | bisacodyl | 19090 | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | bisacodyl | 19090 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | bisacodyl | 19090 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | bisacodyl | 19090 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | bisacodyl | 19090 | drug-path |
| Long-term potentiation | R-HSA-9620244 | map04720 | bisacodyl | 19090 | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | bisacodyl | 19090 | drug-path |
| Asthma | R-HSA-444620 | map05310 | bisacodyl | 19090 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | bisacodyl | 19090 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | bisacodyl | 19090 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | bisacodyl | 19090 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | bisacodyl | 19090 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | bisacodyl | 19090 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | bisacodyl | 19090 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | bisacodyl | 19090 | drug-path |